LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

Search

Perrigo Co PLC

Avatud

SektorTervishoid

26.98 2.9

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

26.25

Max

26.98

Põhinäitajad

By Trading Economics

Sissetulek

38M

-6.4M

Müük

-94M

1B

P/E

Sektori keskmine

2,570

56.602

Aktsiakasum

0.6

Dividenditootlus

4.29

Kasumimarginaal

-0.613

Töötajad

8,379

EBITDA

13M

127M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+30.28% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

4.29%

2.45%

Järgmine tulemuste avaldamine

1. aug 2025

Järgmine dividendimakse kuupäev

17. juuni 2025

Järgmine aktsia dividendi kuupäev (ex-date)

30. mai 2025

Turustatistika

By TradingEconomics

Turukapital

349M

3.7B

Eelmine avamishind

24.08

Eelmine sulgemishind

26.98

Uudiste sentiment

By Acuity

15%

85%

18 / 382 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

Perrigo Co PLC Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

28. veebr 2025, 17:42 UTC

Suurimad hinnamuutused turgudel

Perrigo Shares Jump on FDA's Move to Reclassify Wisconsin Infant-Formula Plant

27. veebr 2025, 23:52 UTC

Tulu

Perrigo Gets Facility Reclassification From FDA as 4Q Profit, Revenue Fall

Võrdlus sarnastega

Hinnamuutus

Perrigo Co PLC Prognoos

Hinnasiht

By TipRanks

30.28% tõus

12 kuu keskmine prognoos

Keskmine 34.25 USD  30.28%

Kõrge 42 USD

Madal 27 USD

Põhineb 4 Wall Streeti analüütiku instrumendi Perrigo Co PLC 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

4 ratings

2

Osta

2

Hoia

0

Müü

Tehniline skoor

By Trading Central

25.22 / 26.85Toetus ja vastupanu

Lühikene perspektiiv

Strong Bullish Evidence

Keskpikk perspektiiv

Strong Bullish Evidence

Pikk perspektiiv

Bullish Evidence

Sentiment

By Acuity

18 / 382 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Perrigo Co PLC

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.